REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,843 | -26.8% | 175 | -34.7% | 0.00% | -33.3% |
| Q1 2023 | $24,367 | +139.3% | 268 | 0.0% | 0.00% | +200.0% |
| Q4 2022 | $10,181 | +45.4% | 268 | -6.0% | 0.00% | 0.0% |
| Q3 2022 | $7,000 | -96.1% | 285 | -95.2% | 0.00% | -95.8% |
| Q2 2022 | $179,000 | -78.9% | 5,885 | -77.3% | 0.02% | -76.7% |
| Q1 2022 | $848,000 | +60.6% | 25,882 | +29.2% | 0.10% | +63.5% |
| Q4 2021 | $528,000 | +52700.0% | 20,026 | +153946.2% | 0.06% | – |
| Q3 2021 | $1,000 | -50.0% | 13 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 13 | +30.0% | 0.00% | – |
| Q1 2021 | $1,000 | -66.7% | 10 | -60.0% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | +200.0% | 25 | +150.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 10 | -37.5% | 0.00% | – |
| Q2 2020 | $2,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |